Skip to main content
. Author manuscript; available in PMC: 2013 Jun 14.
Published in final edited form as: Lab Invest. 2010 Apr 19;90(6):812–823. doi: 10.1038/labinvest.2010.73

Figure 5.

Figure 5

Phenotype of CD45+/pro-Col-1α+ cells in SSc-ILD and aged, healthy controls A. PerCP isotype control (X axis) vs. Anti-CD45-APC (Y axis).This control was used to set the negative gate for PerCP. B. Anti-CD45-PerCP isotype control (X axis) vs. APC isotype control (Y axis). This control was used to set the negative gate for APC. C. Anti-pro-Col-Iα (X axis) vs. anti-CD45 (Y axis) on PBMCs from a subject > 60 years old. D. Anti-CD34 (X axis) vs anti-CD14 (Y axis) on the double positive population seen in C. E. Anti-pro-Col-1α (X axis) vs. anti-CD45 (Y axis) on PBMCs from a patient with SSc-ILD. F. Anti-CD34 (X axis) vs anti-CD14 (Y axis) on the double positive population seen in E. G-J: Comparison of CD34+ CD14- (G), CD14+ CD34+ (H), CD34-CD14+ (I) and CD14-CD34- (J) Populations in the pro-Col-1α+ cells obtained from (left to right) subjects greater than 60 years old (n = 10, black bar) and those with SSc-ILD (n = 7, slanted bar). Data are expressed as mean ± SEM. *p<0.05, **p<0.01.

HHS Vulnerability Disclosure